HDAX Therapeutics
PrivateLast Round
Seed
Sep 5, 2024
Total Funding Raised
$4.02M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
HDAX Therapeutics is a biotechnology company developing small molecule therapeutics targeting HDAC6 for the treatment of neurological and cardiometabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HDAX Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
HDAX Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 5, 2024 | ||||
| Grant | Jul 8, 2024 | ||||
| Grant | Nov 13, 2023 | ||||
| Grant | Oct 12, 2023 |
Key People
Founding team and executive leadership
HDAX Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SeedFolio | Seed |
| TIAP | Seed |
| FACIT | Seed |
| Eos | Seed |
| Ontario Centre of Innovation | Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
Open roles tripled to 3, representing 21% of headcount.
HDAX Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HDAX Therapeutics's valuation, stock price, and market status.